Mitigating Non-Specific Adsorption in Size Exclusion Chromatography: The Welch Xtimate Bio SEC Solution

In the modern biopharmaceutical landscape, a diverse array of "star molecules"—including antibodies, recombinant proteins, and antibody-drug conjugates (ADCs)—has emerged as an elite force in the treatment of tumors, autoimmune disorders, and metabolic diseases.

However, these protein samples are characterized by high molecular weights and intricate structures. They are inherently susceptible to instability, often "clumping" into aggregates or "breaking down" into fragments.

These molecular size variants are significant concerns for drug developers. Not only can they lead to a reduction in therapeutic efficacy, but they may also trigger dangerous immune responses in patients. For this reason, it is imperative to rigorously monitor the "physical stature" of these molecules during the manufacturing process to ensure they remain in an optimal state.

Size Exclusion Chromatography, or SEC, serves as the primary technique for separating proteins based on their molecular dimensions. The separation mechanism is governed by the pore size within the stationary phase:

• Large Molecules: Unable to enter the small pores, these molecules are excluded and elute rapidly.
• Medium Molecules: These enter a portion of the pore network and elute after the large molecules.
• Small Molecules: These traverse the full "maze" of the pores, resulting in the longest residence time and the final elution.

While the principle of size exclusion chromatography appears straightforward, practical application often presents challenges. Traditional silica-based SEC columns can behave like "magnets," unintentionally adsorbing proteins that possess strong charges or high hydrophobicity. This adsorption leads to peak tailing and a significant loss in analytical sensitivity.

To address the challenges posed by "sticky" proteins, Welch Materials has developed the Xtimate Bio SEC column. This technology utilizes silica microspheres bonded with a uniform, nano-thickness hydrophilic polymer layer. This coating acts as an "invisible raincoat," effectively shielding the underlying silanol groups that typically cause sample adsorption. This modification ensures that proteins pass through the column smoothly, maintaining peak integrity.

Chromatographic conditions:

• Column: Xtimate Bio SEC-120 (4.6×300 mm, 5 µm)
• Mobile phase: 150 mM phosphate buffer (pH 6.8)
• Detector wavelength: 215 nm
• Column temperature: 25 °C
• Flow rate: 0.35 mL/min
• Injection volume: 10 µL
• Concentration: 50 µg/mL

Chromatogram vs. a competitor column (red):

Achieving high-resolution separation requires not only a good column, but also the strategic selection of mobile phases tailored to the specific nature of the analyte.

• Recombinant Protein Purity Testing: A buffer consisting of 0.1M Phosphate and 0.15M Sodium Chloride (pH 6.8) is recommended.
• Routine Antibody Analysis: In accordance with USP <129> standards, a mobile phase of 0.2M Potassium Phosphate and 0.25M Potassium Chloride (pH 6.2) is an effective choice.
• Hydrophobic Antibodies and ADCs: To mitigate tailing caused by strong hydrophobic interactions, the addition of 0–20% Isopropanol to the mobile phase is recommended.